Aller au contenu principal
Accès ouvert déclaré 2026 article

Metabolic outcomes in ACTH-independent hypercortisolism: medical therapy vs. adrenalectomy in a monocentric retrospective study

0Citations signalées — pas une note de qualité
4Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Excessive cortisol secretion is responsible for metabolic complications, increasing morbidity and mortality. Normalizing cortisol levels with surgery or medical treatments are the most effective ways to limit these complications, but few studies have compared these two strategies specifically on metabolic complications. This observational, retrospective, monocentric study included 62 patients with confirmed endogenous ACTH-independent hypercortisolism followed in our department between January 2019 and January 2024. Patients were included in three groups: surgery ( n = 42), medication ( n = 13), and observation ( n = 7). Metabolic complications were assessed at baseline, 6 months and 12 months. We compared the evolution of complications depending on the therapeutic strategy and according to the underlying etiology of hypercortisolism. After 6 months, patients in both surgery and medication group showed improvements in cortisol levels, weight, blood pressure, lipid profile, diabetes, and liver parameters. Weight loss was higher in the medication group (-1.61 VS + 0,25 kg/m² in surgery group) while there was no difference for the other parameters. This difference was persistentat 12 months. Patients with primary bilateral macronodular adrenocortical hyperplasia (PBMAH) who received medication showed a higher reduction in BMI (-1,98 VS + 0,68 kg/m²), systolic and diastolic blood pressure (-11,6 VS + 3 and − 4,5 VS + 5 mmHg respectively) than operated patients. No significant differences were observed for other etiologies. Our study suggests that medical treatment is more effective than surgery to improve weight in ACTH-independent hypercortisolism, especially in patients with PBMAH. Treatment modality does not appear to have any impact on other short-term metabolic complications.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Metabolic outcomes in ACTH-independent hypercortisolism: medical therapy vs. adrenalectomy in a monocentric retrospective study
Date Crossref
03/09/2026
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and DisordersAdrenal and Paraganglionic Tumors

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.